Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.

Mice deficient in Schnurri-3 (SHN3; also known as HIVEP3) display increased bone formation, but harnessing this observation for therapeutic benefit requires an improved understanding of how SHN3 functions in osteoblasts. Here we identified SHN3 as a dampener of ERK activity that functions in part downstream of WNT signaling in osteoblasts. A D-domain motif within SHN3 mediated the interaction with and inhibition of ERK activity and osteoblast differentiation, and knockin of a mutation in Shn3 that abolishes this interaction resulted in aberrant ERK activation and consequent osteoblast hyperactivity in vivo. Additionally, in vivo genetic interaction studies demonstrated that crossing to Lrp5(-/-) mice partially rescued the osteosclerotic phenotype of Shn3(-/-) mice; mechanistically, this corresponded to the ability of SHN3 to inhibit ERK-mediated suppression of GSK3β. Inducible knockdown of Shn3 in adult mice resulted in a high-bone mass phenotype, providing evidence that transient blockade of these pathways in adults holds promise as a therapy for osteoporosis.

[1]  A. Kawanami,et al.  Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Play Essential Roles in Osteoblast Differentiation and in Supporting Osteoclastogenesis , 2009, Molecular and Cellular Biology.

[2]  Walter Birchmeier,et al.  Multiple roles of mesenchymal β-catenin during murine limb patterning , 2006 .

[3]  Jun Qin,et al.  Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .

[4]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[5]  Walter Birchmeier,et al.  Multiple roles of mesenchymal beta-catenin during murine limb patterning. , 2006, Development.

[6]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[7]  L. Glimcher,et al.  Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3 , 2010, Proceedings of the National Academy of Sciences.

[8]  Stephen N. Jones,et al.  A Runx2 threshold for the cleidocranial dysplasia phenotype. , 2008, Human molecular genetics.

[9]  Walter Birchmeier,et al.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. , 2005, Developmental cell.

[10]  Xi He,et al.  Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. , 2012, Cold Spring Harbor perspectives in biology.

[11]  Jae-Hyuck Shim,et al.  Control of bone resorption in mice by Schnurri-3 , 2012, Proceedings of the National Academy of Sciences.

[12]  S. Ishii,et al.  Schnurri‐2 deficiency counteracts against bone loss induced by ovariectomy , 2011, Journal of cellular physiology.

[13]  S. Goueli,et al.  Selective in Vivo Inhibition of Mitogen-activated Protein Kinase Activation Using Cell-permeable Peptides* 210 , 2002, The Journal of Biological Chemistry.

[14]  Michael D. Schneider,et al.  The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. , 2010, The Journal of clinical investigation.

[15]  F. Mseeh,et al.  Lrp5 functions in bone to regulate bone mass , 2011, Nature Medicine.

[16]  Richard J. Edwards,et al.  ELM—the database of eukaryotic linear motifs , 2011, Nucleic Acids Res..

[17]  Lai-Chu Wu.  ZAS: C2H2 zinc finger proteins involved in growth and development. , 2002, Gene Expression.

[18]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[19]  C. Marshall,et al.  The sevenmaker gain‐of‐function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action , 1994, FEBS letters.

[20]  Toby J. Gibson,et al.  iELM—a web server to explore short linear motif-mediated interactions , 2012, Nucleic Acids Res..

[21]  Renny T. Franceschi,et al.  Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development , 2007, The Journal of cell biology.

[22]  B. Olsen,et al.  Wnt/β-Catenin—A Canonical Tale of Cell-Fate Choice in the Vertebrate Skeleton , 2005 .

[23]  Bo Zhou,et al.  Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Radha Akella,et al.  Unique MAP Kinase binding sites. , 2008, Biochimica et biophysica acta.

[25]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[26]  L. Glimcher,et al.  Schnurri-3: a key regulator of postnatal skeletal remodeling. , 2007, Advances in experimental medicine and biology.

[27]  Charles P. Lin,et al.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. , 2012, Cell stem cell.

[28]  B. Williams,et al.  Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. , 2011, Developmental biology.

[29]  M. Glimcher,et al.  Regulation of Adult Bone Mass by the Zinc Finger Adapter Protein Schnurri-3 , 2006, Science.

[30]  Hans Clevers,et al.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.

[31]  H. Schaeffer,et al.  A Mammalian Scaffold Complex That Selectively Mediates MAP Kinase Activation , 1998 .

[32]  S. Gygi,et al.  MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. , 2011, The Journal of clinical investigation.

[33]  A. Sharrocks,et al.  Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.

[34]  A. Sharrocks,et al.  Specificity Determinants in MAPK Signaling to Transcription Factors* , 2002, The Journal of Biological Chemistry.

[35]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[36]  B. Alman,et al.  Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing , 2007, PLoS medicine.

[37]  齋田 良知.  Lack of Schnurri-2 expression associates with reduced bone remodeling and osteopenia , 2007 .